Bank of New York Mellon Corp - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 71 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$32,000
-43.9%
30,093
-10.7%
0.00%
Q2 2019$57,000
-89.9%
33,697
-80.0%
0.00%
Q1 2019$567,000
+21.9%
168,223
+5.7%
0.00%
Q4 2018$465,000
-52.8%
159,120
-0.4%
0.00%
Q3 2018$985,000
-10.8%
159,795
+6.8%
0.00%
Q2 2018$1,104,000
+53.8%
149,652
+36.7%
0.00%
Q1 2018$718,000
-21.3%
109,440
+0.8%
0.00%
Q4 2017$912,000
-34.6%
108,518
-10.1%
0.00%
Q3 2017$1,394,000
-2.8%
120,683
-1.7%
0.00%
Q2 2017$1,434,000
+21.1%
122,773
+28.0%
0.00%
Q1 2017$1,184,000
-8.6%
95,934
+1.0%
0.00%
Q4 2016$1,295,000
-24.7%
94,999
+10.0%
0.00%
-100.0%
Q3 2016$1,719,000
+61.1%
86,386
+4.9%
0.00%
Q2 2016$1,067,000
+97.2%
82,348
+42.4%
0.00%
Q1 2016$541,000
-40.8%
57,810
+28.1%
0.00%
Q4 2015$914,000
+27.1%
45,118
-8.7%
0.00%
Q3 2015$719,000
-15.3%
49,419
+23.8%
0.00%
Q2 2015$849,000
+56.1%
39,923
+69.9%
0.00%
Q1 2015$544,00023,4960.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders